Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions

NCT01516723 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Disease
Coronary Stenosis

Interventions

DEVICE: Hybrid sirolimus- and everolimus-eluting stents (ORSIRO, XIENCE PRIME)

Sponsor

R&D Cardiologie

Collaborators

[object Object]